<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="3692">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04668196</url>
  </required_header>
  <id_info>
    <org_study_id>PR(AG)265/2020</org_study_id>
    <nct_id>NCT04668196</nct_id>
  </id_info>
  <brief_title>Noninvasive Respiratory Support in COVID-19 (CATCOVID-AIR)</brief_title>
  <acronym>CATCOVID-AIR</acronym>
  <official_title>Noninvasive Respiratory Support Outside the Intensive Care Unit in COVID-19 Pneumonia: a Multicentric Study (CATCOVID-AIR)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitari Vall d'Hebron Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Barcelona Institute for Global Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital Universitari Vall d'Hebron Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      COVID-19 pneumonia can cause severe acute hypoxemic respiratory failure. The usefulness of&#xD;
      noninvasive respiratory support (NIRS), by means of nasal high-flow oxygen (NHFO), continuous&#xD;
      positive airway pressure (CPAP), or noninvasive ventilation (NIV), established outside the&#xD;
      intensive care unit, is unknown. The aim of this multicenter, retrospective, longitudinal&#xD;
      study is to compare the effectiveness of these treatments to prevent death or endotracheal&#xD;
      intubation at day 28, and what factors, related to the disease or to the characteristics of&#xD;
      the treatment itself, can condition its success or failure.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Multicenter, retrospective, longitudinal study in consecutive adult COVID-19 patients with&#xD;
      acute respiratory failure, requiring noninvasive respiratory support (NIRS) outside the&#xD;
      intensive care unit (ICU) in 10 hospitals in Catalonia (Spain). Demographic, laboratory,&#xD;
      clinical and noninvasive respiratory support data will be collected and analyzed according to&#xD;
      the primary outcome (death or endotracheal intubation at day 28) and secondary outcomes (see&#xD;
      the dedicated section).&#xD;
&#xD;
      During the hospitalization, patients were treated according to the standard procedures of the&#xD;
      participating centers. This study is observational and no randomization have been performed.&#xD;
&#xD;
      Patients were followed up to either 28-days or hospital discharge if still hospitalized at&#xD;
      day 28 from NIRS initiation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 22, 2020</start_date>
  <completion_date type="Anticipated">January 2021</completion_date>
  <primary_completion_date type="Anticipated">January 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Treatment failure</measure>
    <time_frame>28 days within noninvasive respiratory support initiation</time_frame>
    <description>Death or endotracheal intubation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>28-day mortality</measure>
    <time_frame>28 days within noninvasive respiratory support initiation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital mortality</measure>
    <time_frame>Until 28 days from noninvasive respiratory support initiation</time_frame>
    <description>Any death during hospital stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endotracheal intubation</measure>
    <time_frame>28 days within noninvasive respiratory support initiation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of hospital stay</measure>
    <time_frame>Until 28 days from noninvasive respiratory support initiation</time_frame>
    <description>Time between admission and discharge from hospital or death in hospital</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Covid19</condition>
  <condition>Acute Respiratory Failure</condition>
  <condition>Corona Virus Infection</condition>
  <arm_group>
    <arm_group_label>High-flow nasal cannula treatment</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Continuous positive airway pressure (CPAP) treatment</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Noninvasive ventilation treatment</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>High-flow nasal cannula treatment</intervention_name>
    <description>Standard operating procedures represented by hihg-flow nasal cannula oxygen therapy</description>
    <arm_group_label>High-flow nasal cannula treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Continuous positive airway pressure (CPAP) treatment</intervention_name>
    <description>Standard operating procedures represented by continuous positive airway pressure (CPAP) therapy</description>
    <arm_group_label>Continuous positive airway pressure (CPAP) treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Noninvasive ventilation treatment</intervention_name>
    <description>Standard operating procedures represented by noninvasive ventilation treatment</description>
    <arm_group_label>Noninvasive ventilation treatment</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        COVID19 patients treated by noninvasive respiratory support (nasal high-flow oxygen, CPAP,&#xD;
        or noninvasive ventilation), initiated outside the intensive care unit.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  COVID-19 pneumonia confirmed with polymerase chain reaction (PCR).&#xD;
&#xD;
          -  Acute respiratory failure.&#xD;
&#xD;
          -  Treated by noninvasive respiratory support (nasal high-flow oxygen, CPAP or&#xD;
             noninvasive ventilation), initiated outside the intensive care unit.&#xD;
&#xD;
          -  Age &gt; 18 years&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Acute respiratory failure not related to COVID-19&#xD;
&#xD;
          -  Hypercapnic acute respiratory failure&#xD;
&#xD;
          -  Early intolerance to treatment&#xD;
&#xD;
          -  Nosocomial infection&#xD;
&#xD;
          -  Pregnant woman&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Júlia Sampol, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital Universitari Vall d'Hebron Research Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sergi Marti, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitari Vall d'Hebron Research Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sergi Marti, MD PhD</last_name>
    <phone>+34 93 274 61 57</phone>
    <email>smarti@vhebron.net</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mercedes Pallero, MD PhD</last_name>
    <phone>+34 93 274 61 57</phone>
    <email>mpallero@vhebron.net</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Germans Trias i Pujol</name>
      <address>
        <city>Badalona</city>
        <state>Barcelona</state>
        <zip>08916</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antoni Marin Muñiz, MD</last_name>
      <email>ammuniz.germanstrias@gencat.cat</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital General de Granollers</name>
      <address>
        <city>Granollers</city>
        <state>Barcelona</state>
        <zip>08402</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julia Tarrega, MD</last_name>
      <email>30778jtc@comb.cat</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital de Bellvitge</name>
      <address>
        <city>Hospitalet de Llobregat</city>
        <state>Barcelona</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ana Cordoba, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fundació Althaia</name>
      <address>
        <city>Manresa</city>
        <state>Barcelona</state>
        <zip>08243</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Oscar Bernadich, MD</last_name>
      <email>obernadich@althaia.cat</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Corporació Sanitària Parc Taulí</name>
      <address>
        <city>Sabadell</city>
        <state>Barcelona</state>
        <zip>08208</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manel Lujan, MD PhD</last_name>
      <email>mlujan@tauli.cat</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitari Mútua Terrassa</name>
      <address>
        <city>Terrassa</city>
        <state>Bardelona</state>
        <zip>08221</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lourdes Lozano, MD</last_name>
      <email>llozano@mutuaterrassa.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital del Mar, Parc de Salut Mar</name>
      <address>
        <city>Barcelona</city>
        <zip>08003</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juana Martinez Llorens, Md, PhD</last_name>
      <email>JMartinezL@parcdesalutmar.cat</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital de la Santa Creu i Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <zip>08025</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patricia Peñacoba, MD</last_name>
      <email>ppenacoba@santpau.cat</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Vall d'Hebron</name>
      <address>
        <city>Barcelona</city>
        <zip>08035</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sergi Marti, MD PhD</last_name>
      <phone>0034932746157</phone>
      <email>smarti@vhebron.net</email>
    </contact>
    <contact_backup>
      <last_name>Mercedes Pallero, MD PhD</last_name>
      <phone>0034932746157</phone>
      <email>mpallero@vhebron.net</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital Dr.Josep Trueta</name>
      <address>
        <city>Girona</city>
        <zip>17007</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gladis Sabater, MD</last_name>
      <email>gsabater.girona.ics@gencat.cat</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 11, 2020</study_first_submitted>
  <study_first_submitted_qc>December 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 16, 2020</study_first_posted>
  <last_update_submitted>December 13, 2020</last_update_submitted>
  <last_update_submitted_qc>December 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Noninvasive ventilation</keyword>
  <keyword>High-flow nasal cannula</keyword>
  <keyword>Severe Acute Respiratory Syndrome</keyword>
  <keyword>Respiratory Failure</keyword>
  <keyword>Respiratory Tract Diseases</keyword>
  <keyword>Coronavirus Infection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronavirus Infections</mesh_term>
    <mesh_term>Severe Acute Respiratory Syndrome</mesh_term>
    <mesh_term>Respiratory Insufficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

